Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group, (The) (2021) Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397 (10274). pp. 605-612. ISSN 0140-6736

Abstract

Metadata

Authors/Creators:
  • RECOVERY Collaborative Group, (The)
Copyright, Publisher and Additional Information: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Dates:
  • Accepted: 14 January 2021
  • Published (online): 2 February 2021
  • Published: 13 February 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Mar 2021 11:16
Last Modified: 12 Mar 2021 11:16
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S0140-6736(21)00149-5
Related URLs:

Share / Export

Statistics